Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Aluminum vaccine adjuvants: are they safe?

Tomljenovic L, Shaw CA.

Curr Med Chem. 2011;18(17):2630-7.

PMID:
21568886
2.

Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations.

Tomljenovic L, Shaw CA.

Lupus. 2012 Feb;21(2):223-30. doi: 10.1177/0961203311430221.

PMID:
22235057
3.

Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?

Tomljenovic L, Shaw CA.

J Inorg Biochem. 2011 Nov;105(11):1489-99. doi: 10.1016/j.jinorgbio.2011.08.008. Epub 2011 Aug 23.

PMID:
22099159
4.

[Aluminum as an adjuvant in vaccines and post-vaccine reactions].

Fiejka M, Aleksandrowicz J.

Rocz Panstw Zakl Hig. 1993;44(1):73-80. Review. Polish.

PMID:
8235346
5.

Aluminum toxicokinetics regarding infant diet and vaccinations.

Keith LS, Jones DE, Chou CH.

Vaccine. 2002 May 31;20 Suppl 3:S13-7. Review.

PMID:
12184359
6.

Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?

Shaw CA, Li D, Tomljenovic L.

Immunotherapy. 2014;6(10):1055-71. doi: 10.2217/imt.14.81. Review.

PMID:
25428645
7.

Updated aluminum pharmacokinetics following infant exposures through diet and vaccination.

Mitkus RJ, King DB, Hess MA, Forshee RA, Walderhaug MO.

Vaccine. 2011 Nov 28;29(51):9538-43. doi: 10.1016/j.vaccine.2011.09.124. Epub 2011 Oct 11.

PMID:
22001122
8.
9.

Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine.

Kuroda Y, Nacionales DC, Akaogi J, Reeves WH, Satoh M.

Biomed Pharmacother. 2004 Jun;58(5):325-37. Review.

PMID:
15194169
10.

The global impact of vaccines containing aluminium adjuvants.

Clements CJ, Griffiths E.

Vaccine. 2002 May 31;20 Suppl 3:S24-33. Review.

PMID:
12184361
11.

Vaccine adjuvants.

Macy DW.

Semin Vet Med Surg (Small Anim). 1997 Aug;12(3):206-11. Review.

PMID:
9283246
12.

Adjuvants for human vaccines--current status, problems and future prospects.

Gupta RK, Siber GR.

Vaccine. 1995 Oct;13(14):1263-76. Review.

PMID:
8585280
13.
14.

Adjuvants and autoimmunity.

Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y.

Lupus. 2009 Nov;18(13):1217-25. doi: 10.1177/0961203309345724. Review.

PMID:
19880572
15.

Public health. Aluminum is put on trial as a vaccine booster.

Malakoff D.

Science. 2000 May 26;288(5470):1323-4. No abstract available.

PMID:
10847840
16.

[Adverse reactions to vaccines].

Eseverri JL, Ranea S, Marin A.

Allergol Immunopathol (Madr). 2003 May-Jun;31(3):125-38. Review. Spanish.

PMID:
12783762
17.

Itching nodules and hypersensitivity to aluminium after the use of adsorbed vaccines from SSI.

Thierry-Carstensen B, Stellfeld M.

Vaccine. 2004 May 7;22(15-16):1845. No abstract available.

PMID:
15121293
18.

Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants.

Berthold I, Pombo ML, Wagner L, Arciniega JL.

Vaccine. 2005 Mar 14;23(16):1993-9.

PMID:
15734073
19.

Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants.

Jendrek S, Little SF, Hem S, Mitra G, Giardina S.

Vaccine. 2003 Jun 20;21(21-22):3011-8.

PMID:
12798645
20.

Investigation in a model system of the effects of combinations of anthrax and pertussis vaccines administered to service personnel in the 1991 Gulf War.

Rijpkema SG, Adams T, Rigsby P, Xing DK, Corbel MJ.

Hum Vaccin. 2005 Jul-Aug;1(4):165-9. Epub 2005 Jul 1.

PMID:
17012879
Items per page

Supplemental Content

Write to the Help Desk